BCBS of Tennessee to Drop OxyContin Coverage in 2019
BlueCross BlueShield of Tennessee will stop covering the prescription opioid OxyContin beginning January 1, 2019.
BlueCross BlueShield of Tennessee will stop covering the prescription opioid OxyContin beginning January 1, 2019.
Physician burnout increased from 45.5 percent to 54.4 percent between 2011 and 2014, according to an article in the American Journal of Medicine.
A study published in JAMA examined the frequency of opioid overdoses after discharge from surgery.
Massachusetts currently leads the nation in decreasing opioids prescription, according to a Blue Cross Blue Shield report cited by The Boston Herald. Blue Cross Blue Shield's survey illustrated 51 percent fewer opioid prescriptions written in Massachusetts in 2017 than 2013; specifically, Bay State physicians wrote 193 opioids prescriptions per 1,000 Blue Cross-insured members. The national average is 394 per 1,000 members. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.
The AMA's latest National Economic Impact of Physicians report provides data that can be used by key health care policymakers, legislators and thought leaders. It also demonstrates how physician practices both ensure the health and well-being of communities as well as support local economies and enable jobs, growth and prosperity.
The AMA's latest National Economic Impact of Physicians report provides data that can be used by key health care policymakers, legislators and thought leaders. It also demonstrates how physician practices both ensure the health and well-being of communities as well as support local economies and enable jobs, growth and prosperity.
Massachusetts currently leads the nation in decreasing opioids prescription, according to a Blue Cross Blue Shield report cited by The Boston Herald. Blue Cross Blue Shield's survey illustrated 51 percent fewer opioid prescriptions written in Massachusetts in 2017 than 2013; specifically, Bay State physicians wrote 193 opioids prescriptions per 1,000 Blue Cross-insured members. The national average is 394 per 1,000 members. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.
Although needle exchanges and safe injection sites have numerous studies backing their effectiveness in fighting opioid addiction, a recent study revealed many Americans oppose both — a stigma that could harm the nation's response to the opioid epidemic, Vox reports. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.
Although needle exchanges and safe injection sites have numerous studies backing their effectiveness in fighting opioid addiction, a recent study revealed many Americans oppose both — a stigma that could harm the nation's response to the opioid epidemic, Vox reports. The study, published in Preventive Medicine, analyzed data from over 1,000 Americans. In a survey, the researchers queried respondents' attitudes on needle exchanges, (where people can dispose of used syringes and get sterile ones), safe injection sites (where people can use drugs under medical supervision) and broader opinions on addiction.
Hinge Health, a San Francisco startup that developed a 12-week remote monitoring program to reduce chronic knee pain and back pain, has published the results of a randomized control study to illustrate the effectiveness of its program for chronic knee pain. The program is intended to provide a noninvasive alternative to surgery to reduce chronic musculoskeletal pain.